Blue Water Vaccines Inc to Present at World Vaccine Congress Washington 2022
April 11, 2022 09:56 ET
|
Blue Water Vaccines Inc.
BWV-101 - Universal Influenza Program: Developing a novel vaccine to protect against all influenza strains using groundbreaking mathematical models and research CINCINNATI, April 11, 2022 (GLOBE...
Blue Water Vaccines Announces Publication in Nano Research Supporting Novel S&P Vaccine Platform Versatility
March 22, 2022 07:00 ET
|
Blue Water Vaccines Inc.
Blue Water Vaccines has exclusive, global licensing rights to Cincinnati Children’s Hospital Medical Center’s novel virus-like particle (VLP) vaccine platform.The data supports BWV’s ongoing...
Blue Water Vaccines Announces Closing of Initial Public Offering
February 23, 2022 16:51 ET
|
Blue Water Vaccines Inc.
CINCINNATI, Feb. 23, 2022 (GLOBE NEWSWIRE) -- Blue Water Vaccines Inc. ("BWV" or "Blue Water Vaccines" or the "Company"), a biopharmaceutical company developing vaccines, today announced the closing...
Blue Water Vaccines Announces Pricing of approximate $20M Initial Public Offering
February 17, 2022 19:22 ET
|
Blue Water Vaccines Inc.
CINCINNATI, Feb. 17, 2022 (GLOBE NEWSWIRE) -- Blue Water Vaccines, Inc. ("BWV" or "Blue Water Vaccines" or the "Company"), a biopharmaceutical company developing vaccines, today announced the...